35 results
6-K
EX-99.1
GNFT
Genfit
20 Sep 23
Current report (foreign)
4:44pm
with Versantis AG ("Versantis") to acquire all the shares and voting rights of Versantis, a private Swiss-based clinical stage biotechnology company focused … -in and registered for at least two years, is entitled to double voting rights under the conditions prescribed by law (Article 32 of the Company's bylaws
F-3
GNFT
Genfit
18 Apr 23
Shelf registration (foreign)
2:33pm
chief executive officer, one of its deputy chief executive officer, an observer or a shareholder that holds over 10% of the voting rights, or further … , if a legal person, a controlling company within the meaning of article L.233-3 of the French Commercial Code holding over 10% of the voting rights
6-K
EX-99.1
1xxltl4 dt82o0t4o
28 Sep 22
GENFIT Reports First Half-Year 2022 Financial Results and Provides Corporate Update
4:13pm
6-K
EX-99.2
itviotgj8bvaox5
28 Sep 22
GENFIT Reports First Half-Year 2022 Financial Results and Provides Corporate Update
4:13pm
6-K
EX-99.1
s4ksce713nb5mpbr4 fi
19 Sep 22
GENFIT to Acquire Clinical-stage Biopharmaceutical Company Versantis, expanding its Portfolio in Liver Diseases
6:10am
6-K
EX-99.1
5ua e0jtdsappcr9i
30 Jun 21
Current report (foreign)
4:18pm